Healthcare

12 Aug 2021  |  North America  |  Market Research

Frost Radar™: Non-Invasive Prenatal Testing, Global, 2021

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

Non-invasive prenatal testing (NIPT) provides an alternative to invasive, higher-risk tests such as amniocentesis, requiring a maternal blood sample to obtain cell-free DNA from both mother and fetus for analysis. Since NIPTs debut in 2011, laboratories and testing companies have made incremental upgrades to their non-invasive screens, improving ac...

During the last decade, adoption of robot-assisted surgery has increased significantly as opportunities have multiplied for performing minimally invasive procedures. Overall, surgical robotic platforms facilitate more precise surgeries and improve the repeatability of procedural movements. These benefits support faster recovery and better outcomes ...

29 Jun 2021  |  North America  |  Market Research

Frost Radar™: Digital Operating Rooms, 2020

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

Hospitals are under extreme pressure to reduce costs and become more profitable. Operating rooms (ORs) drive approximately 60% of revenue in the average hospital. The most critical issues entail finding new methods to reduce human error and improve the efficiency and quality of surgical care. Technology is now available to help hospitals reduce sur...

Pharmaceutical drug discovery and development suffers from declining success rates with new molecules, and the rate of return has shrunk from 16% in 2011 to almost 11% in 2018. Frost & Sullivan finds that traditional solutions focused primarily on data from limited sources and rule-based computational techniques used to address the understanding of...

01 Jun 2021  |  North America  |  Market Research

Frost Radar™: US Population Health Management Market, 2021

A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

Infographics

×

After pausing while the US healthcare industry struggled to contain COVID-19, the stringent audit process for value-based care (VBC) is back in full swing for 90% of Medicare reimbursement that is currently attributed to some form of quality or risk-based payment plan. Additionally, CMS has launched new guidance for value-based reimbursement among ...

01 Feb 2021  |  North America  |  Market Research

Digital Transformation in Imaging Powering the Next Wave of Growth in Informatics

Future Growth Potential Enhanced by Growth Opportunities in Enterprise Imaging IT

Infographics

×

The global medical imaging and informatics industry is undergoing rapid change with the emergence of new technologies, evolving clinical and administrative needs, and the introduction of new policies and regulations, making it necessary for industry participants to continuously innovate to maintain their competitive edge. New technologies such as A...

Global resource constraints on health systems are driving a shift to value-based healthcare to reduce cost, increase access, and improve outcomes. In the United States, resource constraints affect more than 20% of the population. The number of respiratory therapists is declining at a rate of 4% to 7%, while the demand for respiratory specialists wi...

12 Dec 2019  |  North America  |  Market Research

US and EU5 Hand Hygiene Compliance Monitoring Solution Market, Forecast to 2023

Setting a Foundation for Smart Hospitals with Hand Hygiene Compliance and Monitoring Solutions

Infographics

×

Key Issues Addressed

Healthcare-associated infections (HAI) or infections acquired in health-care settings are the most frequent adverse events in healthcare delivery worldwide. Hundreds of millions of patients are affected by health care-associated infections worldwide each year, leading to significant mortality and financial losses for healthcare systems. Hand hygie...

Traditionally, CMOs have thrived by aggregating demand and delivering benefits of economies of scale. However, with the fading era of blockbuster drugs dispensed to large patient pools and shift to precision medicine, focus on niche indications, and increased R&D in biologics, pharma sponsors are increasingly turning to CMOs as strategic partners i...